Cargando…

Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility

BACKGROUND: Protein kinase D (PKD) has been implicated in a wide range of cellular processes and pathological conditions including cancer. However, targeting PKD therapeutically and dissecting PKD-mediated cellular responses remains difficult due to lack of a potent and selective inhibitor. Previous...

Descripción completa

Detalles Bibliográficos
Autores principales:	LaValle, Courtney R, Bravo-Altamirano, Karla, Giridhar, Karthik V, Chen, Jun, Sharlow, Elizabeth, Lazo, John S, Wipf, Peter, Wang, Q Jane
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873968/ https://www.ncbi.nlm.nih.gov/pubmed/20444281 http://dx.doi.org/10.1186/1472-6769-10-5

Ejemplares similares

Design, Synthesis, and Biological Evaluation of PKD Inhibitors
por: George, Kara M., et al.
Publicado: (2011)

New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells
por: Tandon, Manuj, et al.
Publicado: (2013)

Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells
por: Zhang, Liyong, et al.
Publicado: (2017)

Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen
por: Sharlow, Elizabeth R., et al.
Publicado: (2009)

SD-208, a Novel Protein Kinase D Inhibitor, Blocks Prostate Cancer Cell Proliferation and Tumor Growth In Vivo by Inducing G2/M Cell Cycle Arrest
por: Tandon, Manuj, et al.
Publicado: (2015)

Discovery of Diverse Small Molecule Chemotypes with Cell-Based PKD1 Inhibitory Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2011)

Raf Kinase Inhibitor Protein (RKIP) Blocks Signal Transducer and Activator of Transcription 3 (STAT3) Activation in Breast and Prostate Cancer
por: Yousuf, Saad, et al.
Publicado: (2014)

Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer
por: Lazo, John S., et al.
Publicado: (2021)

Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
por: Zhang, Liyong, et al.
Publicado: (2018)

A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis
por: Krainz, Tanja, et al.
Publicado: (2016)

Role of prostatic interstitial cells in prostate motility
por: Lang, Richard J, et al.
Publicado: (2017)

A Targeted Library Screen Reveals a New Inhibitor Scaffold for Protein Kinase D
por: Tandon, Manuj, et al.
Publicado: (2012)

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor
por: McQueeney, Kelley E., et al.
Publicado: (2017)

Neocarzilin A Is a Potent Inhibitor of Cancer Cell Motility Targeting VAT-1 Controlled Pathways
por: Gleissner, Carolin M.-L., et al.
Publicado: (2019)

Effects of a Protein Kinase Inhibitor on Sperm Motility in the Japanese Quail
por: Matsuzaki, Mei, et al.
Publicado: (2017)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

An introduction to probability, decision, and inference
por: LaValle, Irving H.
Publicado: (1970)

Planning Algorithms
por: LaValle, Steven M
Publicado: (2006)

Phosphorylation and interaction of Myopodin by Integrin-Link Kinase Lead to Suppression of Cell Growth and Motility in Prostate Cancer Cells
por: Yu, Yan-Ping, et al.
Publicado: (2011)

Planning algorithms /
por: LaValle, Steven Michael, 1968-
Publicado: (2006)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

β‐Hydroxyisovalerylshikonin Is a Novel and Potent Inhibitor of Protein Tyrosine Kinases
por: Hashimoto, Sachiko, et al.
Publicado: (2002)

Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum
por: Nava, Maria G., et al.
Publicado: (2022)

Regulation of Cell Motility by Mitogen-activated Protein Kinase
por: Klemke, Richard L., et al.
Publicado: (1997)

Protein kinases regulate hyperactivated motility of human sperm
por: Wang, Ya-Yan, et al.
Publicado: (2021)

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
por: Weygant, Nathaniel, et al.
Publicado: (2014)

Inhibition of Mitochondrial Uncoupling Proteins Arrests Human Spermatozoa Motility without Compromising Viability
por: Carrageta, David F., et al.
Publicado: (2023)

Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
por: Kim, Hyung-Gu, et al.
Publicado: (2013)

Identification of potent inhibitors of microtubule affinity regulating kinase for inhibition of tau hyperphosphorylation
por: Levy, Alison, et al.
Publicado: (2013)

Structure of the Human Autophagy Initiating Kinase ULK1 in Complex with Potent Inhibitors
por: Lazarus, Michael B., et al.
Publicado: (2014)

Antineoplastic kinase inhibitors: A new class of potent anti-amoebic compounds
por: Sauvey, Conall, et al.
Publicado: (2021)

Saccharomonosporine A inspiration; synthesis of potent analogues as potential PIM kinase inhibitors
por: AboulMagd, Asmaa M., et al.
Publicado: (2020)

The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
por: Newton, Rebecca, et al.
Publicado: (2016)

High content screening miniaturization and single cell imaging of mature human feeder layer-free iPSC-derived neurons
por: Sharlow, Elizabeth R., et al.
Publicado: (2023)

Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2016)

Bioactive principles from Cordyceps sinensis: A potent food supplement – A review
por: Shashidhar, M.G., et al.
Publicado: (2013)

Expression of LIM kinase 1 is associated with reversible G1/S phase arrest, chromosomal instability and prostate cancer
por: Davila, Monica, et al.
Publicado: (2007)

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
Publicado: (1992)

A Target-Based High Throughput Screen Yields Trypanosoma brucei Hexokinase Small Molecule Inhibitors with Antiparasitic Activity
por: Sharlow, Elizabeth R., et al.
Publicado: (2010)

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
por: Eustace, Alex J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8cdvdmhi7dqll718599kam1d9o